Updated: February 8, 2021
Catalysts are one-time incentive awards (up to $250,000), focused on basic biological/ biomedical research with transformative potential, made to collaborative teams with principals and other strong representation from at least two of the CBC institutions.
Spring 2021 Catalyst Award application submission portal is now OPEN; application submission deadline: February 26, 2021, @5PM.
Updated: February 8, 2021
Accelerator Award is a milestone-driven award program (up to $250,000) focused on translational research toward therapeutics or associated biomarkers and diagnostics.
Spring 2021 Accelerator Award Letter of Intent (LOI) submission portal is now OPEN; LOI submission deadline: March 5, 2021, @5PM.
Updated: February 17, 2021
CBC and the CBC COVID-19 Response Award recipients invite you to attend a series of townhall meetings during which our invited speakers will discuss SARS-CoV-2/COVID-19 biomedical research.
Date: Thursday, February 25, 2021
Time: 4:00PM – 5:30PM
Location: Virtual via ZOOM
Speaker: Elizabeth M. McNally, MD, PhD
Director, Center for Genetic Medicine
Elizabeth J. Ward Professor of Genetic Medicine
Professor of Medicine (Cardiology) and Biochemistry and Molecular Genetics
Northwestern University Feinberg School of Medicine
Dr. McNally will describe findings from the SCAN study and will discuss the next steps associated with this antibody test, including community testing, how the results compare in different neighborhoods, and longitudinal data collection and analysis.
Registration is required. A link to the webinar will be provided upon registration.
UP NEXT IN THE SERIES:
Date: March 25, 2021
Speaker: Emily Landon, MD
Associate Professor of Medicine
Executive Medical Director, Infection Prevention and Control
The University of Chicago
Registration will open on February 26, 2021!
News I February 11, 2021
Over 100 researchers from the 3 CBC universities received up-to-date information regarding the Catalyst and Accelerator Award programs on February 3, 2021.
Success Story I December 22, 2020
▸ CBC Senior Investigator to lead CLP
Featuring CBC Senior Investigator Neil Kelleher, NU
Renown proteomics expert and CBC Senior Investigator Neil Kelleher to become Interim Director of Northwestern’s Chemistry of Life Processes Institute (CLP), effective January 1, 2021.
NEWS I December 22, 2020
▸ 17th Annual CBC Symposium Recap
Virtual Symposium on “Epigenetics & Disease” draws international attention and record attendance
The CBC 17th Annual Symposium: “Epigenetics and Disease” was held virtually on October 30, 2020. Close to 500 participants from around the globe attended the event which included 6 remarkable scientific presentations and a virtual poster session.
Community, Biotech & Entrepreneurship
Posted: February 22, 2021
March 9, 2021
Rosalind Franklin University of Medicine and Science, Women In Bio and SmartHealth Catalyzer
▸ BioPathways + Women In Bio: The Impact of COVID on Abbott’s Innovation
Featuring Andrea Wainer, Executive Vice President, Rapid and Molecular Diagnostics, Abbott
Posted: February 9, 2021
February 12, 2021
NU Innovation and New Ventures Office
▸ Stage-Gates in Drug Discovery
Featuring Jim Audia, former CBC Executive Director
Posted: December 14, 2020
June 10-11 & 14-17, 2021
Biotechnology Innovation Organization (BIO)
▸ BIO International Convention: BIO Digital
Posted: December 21, 2020
New Funding Opportunity
Cures Within Reach is excited to announce our new funding opportunity Request for Proposals (RFP), with up to $50,000 available for clinical repurposing trials impacting veterans in any disease area, including mental health, PTSD and brain injury. Clinical repurposing trials from any US-based institution impacting veterans are eligible. Proposal submissions due February 26, 2021.
▸ Read more
Posted: February 12, 2021
Join Woman In Bio (WIB)-Chicago’s Mentorship, Advisors, Peers, & Sponsorship (MAPS) Program. MAPS is a 6 months mentoring program for everyone trying to connect and learn from people in the Chicago Biotech community to reach their career goals. Complete an application for consideration, due by March 11, 2021.
▸ Read more